High prevalence of intracranial arterial stenosis among acute ischemic stroke patients in a Brazilian center: a transcranial color-coded duplex sonography study

Abstract

Background There is limited data available regarding the prevalence of intracranial arterial stenosis (ICAS) among acute ischemic stroke (AIS) patients in Brazil and Latin America.

Objective The present study sought to investigate the frequency and predictors of ICAS among patients with AIS or transient ischemic attack (TIA) in a Brazilian center, with transcranial color-coded duplex sonography (TCCS) technique.

Methods Consecutive AIS and TIA patients, admitted to an academic public comprehensive stroke center in Brazil from February to December 2014, evaluated by TCCS were prospectively selected. Vascular narrowings > 50% were considered as ICAS, based on ultrasound criteria previously defined in the literature.

Results We assessed 170 consecutive patients with AIS or TIA, of whom 27 (15.9%) were excluded due to an inadequate transtemporal acoustic bone window. We confirmed ICAS in 55 patients (38.5%). The most common location was the proximal segment of the middle cerebral artery (28.2%), followed by the vertebral (15.4%), posterior cerebral (13.6%), terminal internal carotid (9.1%) and basilar (8.2%) arteries. On multivariate models adjusting for potential confounders, systolic blood pressure (OR: 1.03, 95%CI: 1.01–1.04; p = 0.008) was independently associated with ICAS.

Conclusion We found significant ICAS in approximately ⅓ of patients admitted with symptoms of AIS or TIA in a public tertiary academic stroke center in Brazil. The TCCS is an accessible and noninvasive technique that can be used to investigate the presence of moderate and severe ICAS, especially in patients who cannot be exposed to more invasive exams, such as the use of intravenous contrast agents.

Resumo

Antecedentes Dados acerca da prevalência da estenose arterial intracraniana (EAIC) entre os pacientes com acidente vascular isquêmico (AVCi) agudo no Brasil e América Latina são limitados.

Objetivo O presente estudo pretendeu investigar a frequência e os preditores da EAIC nos pacientes AVCi ou ataque isquêmico transitório (AIT) em um centro brasileiro utilizando o Doppler transcraniano colorido (duplex transcraniano).

Métodos Pacientes consecutivos com AVCi ou AIT, admitidos entre fevereiro e dezembro de 2014 em um centro acadêmico brasileiro especializado em doenças cerebrovasculares, foram avaliados prospectivamente com duplex transcraniano. Os estreitamentos vasculares > 50% foram considerados como EAIC, baseado em critérios ultrassonográficos definidos previamente na literatura.

Resultados Foram avaliados 170 pacientes com AVCi ou AIT, dos quais 27 (15,9%) foram excluídos em decorrência da janela óssea transtemporal acústica inadequada. Confirmamos EAIC em 55 pacientes (38,5%). A localização mais comum foi o segmento proximal da artéria cerebral média (28,2%), seguida pelas artérias vertebral (15,4%), cerebral posterior (13,6%), carótida interna terminal (9,1%) e basilar (8,2%). No modelo multivariado, ajustado para os potenciais confundidores, a pressão arterial sistólica aumentada (OR: 1,03; IC 95%: 1,01–1,04; p = 0,008) foi independentemente associada a EAIC.

Conclusão Foi identificada EAIC significativa em quase ⅓ dos pacientes admitidos com sintomas de AVCi ou AIT em um serviço acadêmico público de atendimento especializado em doenças cerebrovasculares. O Doppler transcraniano colorido é uma ferramenta acessível e não invasiva que pode ser utilizada com segurança para a investigação da presença de EAIC moderada ou grave, especialmente nos pacientes que não podem ser expostos a exames complementares mais invasivos com uso de contraste intravenoso.

Keywords

Ischemic Stroke - Ischemic Attack Transient - Intracranial Arterial Diseases - Ultrasonography Doppler Transcranial

Palavras-chave

AVC Isquêmico - Ataque Isquêmico Transitório - Doenças Arteriais Intracranianas - Ultrassonografia Doppler Transcraniana

INTRODUCTION

Intracranial arterial stenosis (ICAS) is still considered the most significant cause of acute ischemic stroke (AIS) worldwide.[1] However, its prevalence in Latin America is largely unknown and variable in different study methodologies and scenarios.[2] In Brazil, data about ICAS frequency within the AIS and TIA populations is insufficient. Patients with ICAS, particularly those with symptomatic stenosis, have a higher risk of recurrent stroke, especially during the first year after the initial stroke.[3] Therefore, it is essential to identify these symptoms promptly in AIS or TIA patients. Furthermore, patients with more than 50% luminal stenosis should be followed closely by aggressive secondary stroke prevention strategies.[4]

Techniques such as digital subtraction (DSA), computed tomographic (CTA), and magnetic resonance (MRA) angiographies are commonly used in developed countries for the diagnosis of ICAS in AIS/TIA patients, but they have limitations such as invasiveness, high cost, contrast toxicity, and high-magnetic field restrictions. Moreover, the low availability and high cost of these modalities in developing countries may also limit their use as routine workup of ICAS as part of the diagnostic assessment of AIS patients, contributing to underestimating the burden of this condition in Brazil.[5] Alternatively, among neuroimaging methods, transcranial color-coded duplex sonography (TCCS) study is a noninvasive, broadly available, and inexpensive method for assessing intracranial blood flow and hemodynamic changes.[6] [7] It is mainly used for the detection of hemodynamically significant ICAS in acute stroke patients. This study aimed to evaluate the frequency and severity of ICAS in patients with AIS and TIA admitted to an academic tertiary stroke center in Brazil using TCCS.

METHODS

Population and inclusion criteria

The study population consisted of all consecutive patients above 18-years-old who were admitted with AIS or TIA and evaluated by TCCS as part of their routine stroke etiologic investigation, selected prospectively from February 2014 to December 2014. During the study period, investigation of the intracranial vasculature using an imaging technique (TCCS or CTA) as part of the routine investigation of all patients suspected of having a stroke. The ethical committee of the Hospital das Clínicas from the Ribeirão Preto Medical School approved this study, and written informed consent was required from all participants. Patients without TCCS in their routine investigation, or those with bilateral inadequate transtemporal acoustic bone window, defined as the absence of visualization of the midbrain and sphenoid wing bone by TCCS on B-mode, as well as those in whom no vascular structure could be identified, were excluded from the study.[8] [9]

Study protocol

The diagnosis of AIS or TIA was performed by an experienced stroke neurologist based on the patients' clinical history, neurological examination, and neuroimaging results. Symptomatic ICAS was defined as the narrowed artery being responsible for new symptoms or ischemia in the corresponding brain region.[10]

The data collected included demographic information, clinical history, and diagnostic workup. On admission, the national institutes of health stroke scale (NIHSS) was used to assess stroke severity, and the modified Rankin scale (mRS) was used to assess functional outcome at discharge and 90 days after the cerebrovascular event.[11] [12] [13]

The personal history of main risk factors for stroke was collected: systemic arterial hypertension, diabetes mellitus, smoking, alcoholism, dyslipidemia, elevated body mass index, atrial fibrillation, and prior occurrence of myocardial infarction, cerebral infarction, and TIA. Blood pressure, capillary glycemia, glycosylated hemoglobin, hemoglobin, hematocrit, and cholesterol levels were also recorded on admission. The definition of the presence of each risk factor was based on the guidelines in force at the time of data collection, as well as on the results of laboratory and imaging tests in the study protocol.

Complementary exams were performed to determine the AIS subtype according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST).[14]

Imaging evaluation

Transcranial color-coded duplex sonography (TCCS) study

A TCCS study was conducted to investigate the presence and severity of ICAS in each target vessel, indicated below. All exams were performed by just one experienced neurosonographer within seven days of hospital admission using a Xario SSA-660A (Toshiba Corp. Tokio, Japan) 2MHz probe.

The study measured the maximum mean flow velocities (MFV) of the following arteries bilaterally: terminal internal carotid artery (TICA), proximal segments (M1 and M2) of the middle cerebral artery (MCA), the anterior cerebral artery (ACA), and the P1 and P2 segments of the posterior cerebral artery (PCA). The vertebral (VA) and basilar (BA) arteries were assessed through suboccipital window.[15]

According to the institutional protocol data were recorded at 0° and corrected by aligning the insonation angle parallel to the blood flow vector whenever necessary.

Ultrasound investigation of cervical carotid and vertebral arteries was also performed through TCCS. If significant stenosis (70%) was found, the patient was excluded from the study as it could interfere with the analysis.

Intracranial arterial stenosis (ICAS) criteria

The following MFV cutoffs on TCCS were used for identification of hemodynamically significant stenosis (≥50% luminal stenosis) according to the previous criteria, established through TCCS ultrasound examination:[16] [17] MCA-MFV > 100 cm/s, TICA MFV > 90 cm/s, VA and BA MFV > 80 cm/s, ACA > 80 cm/s, and PCA >50 cm/s. When the absolute value of velocity did not achieve the criterion, the degree of stenosis was estimated as (1–[MV pre- or post-stenotic / MV intrastenotic] x 100).

Having met the prerequisite of adequate quality of the ultrasound window, we defined occlusion by absent or minimal signals and sub occlusion by blunted signals. We checked all vessels every 2mm of their path, as the possibility of tortuosity could make the examination difficult and simulate occlusion. We also excluded patients with significant cervical ICAS.

In order to confirm the degree of stenosis by TCCS, we compared their findings with CTA, if this test was available, with exams being performed using a Sensation 64 machine (Siemens AG, Erlangen, Germany) and analyzed by experienced radiologist, blinded to the TCCS results, using the Osirix (Bernex, Switzerland) v.6.0.2 imaging software.

Statistical analysis

All analyses were conducted using the Statistical Package Social Sciences (SPSS, IBM Corp., Armonk, NY, USA) version 20.0. Univariate analysis was performed using the Student t, Mann-Whitney U, Chi-squared, or Fisher exact test, as appropriate. Variables with a p-value of less than 0.1 were included in the multivariate analysis. Multivariate logistic regression (backward selection method) was then used to identify independent predictors of stenosis. A p-value of less than 0.05 (2-sided) was considered statistically significant. We evaluated the Cohen Kappa, sensitivity, specificity, and positive and negative predictive values to compare the performance of TCCS with CTA.

RESULTS

We examined 170 subjects, of which 27 (15.9%) were excluded from the study because of inadequate acoustic transtemporal bone windows for TCCS. These patients were similar in baseline characteristics to those with adequate transcranial windows. Of the 143 remaining patients, 89 (62.2%) were men, and 62.9% were White. The mean age was 63.6 ± 11.1 years. Furthermore, 124 (86.7%) participants had AIS, and 19 (13.3%) had TIA. The sample demographic and clinical details are displayed in [Table 1].

Table 1 Baseline characteristics of patients according to TCCS findings

Characteristics	Total n = 143	ICAS ≥ 50%		p-value*
		No = 88 (61.5%)	Yes = 55 (38.5%)
Age, median ± SD*	63.57 ± 11.13	63.15 ± 11.14	64.25 ± 11.18	0.46
Male sex (%)	89 (62.2)	50 (56.8)	39 (70.9)	0.09
Ethnicity#
White	90 (62.9)	52 (59.1)	38 (69.1)	0.44
Risk Factors
Hypertension (%)	110 (76.9)	68 (77.3)	42 (76.4)	0.90
Diabetes (%)	58 (40.6)	38 (43.2)	20 (36.4)	0.41
Current smoker (%)	47 (32.9)	29 (32.9)	18 (32.7)	0.97
Prior stroke or TIA (%)	63 (44.1)	39 (44.3)	24 (43.6)	0.93
Cardiomyopathy (%)	32 (22.4)	19 (21.6)	13 (23.6)	0.77
Atrial fibrillation (%)	27 (18.9)	21 (23.9)	10 (18.2)	0.42
Chagas disease (%)	13 (9.1)	10 (11.4)	3 (5.5)	0.23
Dyslipidemia (%)	56 (39.2)	37 (42.1)	19 (34.5)	0.37
Alcoholism	45 (31.5)	24 (27.3)	21 (38.2)	0.17
Prior aspirin use (%)	59 (41.3)	33 (37.5)	26 (47.3)	0.24
Prior statins use in dyslipidemia (%)	24 (16.8)	15 (17.0)	9 (16.4)	0.62
NIHSS, median (IQR)*	7 (3–15)	6 (3–13)	10 (4–19)	0.004
Glasgow, median (IQR)*	15 (12–15)	15 (13.5–15)	14 (11–15)	0.08
Event type
AIS (%)	124 (86.7)	77 (87.5)	47 (85.5)
TIA (%)	19 (13.3)	11 (12.5)	8 (14.5)	0.55
Non-lacunar#	105 (74.5)	61 (70.1)	44 (81.5)	0.13
BMI median (IQR)*	26.7 (23.9–30.5)	26.4 (23.4–29.5)	27.1 (24.5–31.2)	0.27
Baseline systolic BP, median (IQR)*	150 (132–164)	140 (130–155)	160 (145–170)	< 0.001
Baseline diastolic BP, median (IQR)*	90 (70.5–93.5)	90 (77.5–91.0)	90 (80–95)	0.29
NIHSS 90 days, median (IQR)*#	3 (0–6)	3 (0–5)	3 (0–8)	0.87
mRS 90 days ≥ 3 (%)#	59 (47.2)	35 (45.5)	24 (50.0)	0.62
Mortality < 3 months (%)#	14 (11.2)	6 (7.8)	8 (16.7)	0.57
TOAST
Undetermined	40 (27.9)	34 (38.6)	6 (10.9)
Cardioembolism	41 (28.7)	27 (30.7)	14 (25.5)
Large artery atherosclerosis	41 (28.7)	13 (14.7)	28 (50.9)	< 0.0001
Small artery occlusion	17 (11.9)	11 (12.5)	6 (10.9)
Other determined causes	4 (2.8)	3 (3.4)	1 (1.8)

Abbreviations: AIS, acute ischemic stroke; BMI, body mass index; BP, blood pressure; GCS, Glasgow Coma Scale; IQR, interquartile range; mRS, modified Rankin scale; NIHSS, National Institutes of Health Stroke Scale; SD, standard deviation; TIA, transient ischemic attack; TOAST, Trial of Org 10172 in Acute Stroke Treatment. Notes: *Data expressed as median and interquartile range; # missing data were removed from the analysis.

The TCCS detected ICAS in 55 (38.5%) patients, and 36 (65.5%) were considered symptomatic. Male sex (p = 0.09), NIHSS (p = 0.004), systolic blood pressure on admission (p < 0.001), TOAST classification (p < 0.0001), and high-density lipoprotein (HDL) cholesterol (p = 0.02) had an association ([Tables 1] and [2]). Increased systolic blood pressure on admission was the only factor independently associated with ICAS in the final multivariate logistic regression models (OR: 1.02; 95% confidence interval [CI]: 1.01–1.05; p = 0.008), as shown in [Table 3].

Table 2 Laboratorial baseline characteristics of patients according to TCCS findings

Characteristics; N (IQR)	Total N = 143	ICAS ≥50%		p-value
		No = 88 (61.5%)	Yes = 55 (38.5%)
HbA1C (%)	6.2 (5.6–7.5)	6.1 (5.6–7.2)	6.4 (5.6–8)	0.30
HbA1C ≥6.5 (%)*	40 (44.9)	24 (42.8)	16 (48.5)	0.60
Hemoglobin (g/dL)	14.2 (12.8–15.3)	14.1 (12.9–15.5)	14.4 (12.6–15.1)	0.95
Hematocrit (%)	43 (39–46)	42 (39–46)	43 (38–45)	0.66
Total cholesterol (mg/dL)	173 (144–208)	176 (45–206)	173 (138–208)	0.54
LDL cholesterol (mg/dL)	110 (83–144)	111 (84–144)	102 (83–136)	0.46
HDL cholesterol (mg/dL)	35 (30–43)	36 (30–45)	32 (27–39)	0.02
Triglycerides (mg/dL)	120 (87–165)	119.5 (85–159)	127 (100–168)	0.57

Abbreviations: HbA1C, glycosylated hemoglobin; HDL, high-density lipoprotein; ICA, intracranial arterial stenosis; IQR, interquartile range LDL, low-density lipoprotein.

Note: *values show the number and percentage of patients, missing values were excluded.

Table 3 Association with ICAS in the multivariate analysis

	Stenosis ≥ 50%		OR (95% CI)	p-value
	No = 88 (61.5%)	Yes = 55 (38.5%)
SBP (IQR)	140 (130–155)	160 (145–170)	1.02 (1.01–1.05)	0.008

Abbreviations: CI, confidence interval; ICAS, intracranial arterial stenosis; IQR, interquartile range; OR, odds ratio adjusted; SBP, systolic blood pressure. Note: The variables considered in the model are male sex, NIHSS, Glasgow, systolic blood pressure, and HDL cholesterol.

The frequency of ICAS according to the different locations in proximal arteries is given in [Table 4]. The number of ICAS vessels was one in 25 patients (45.5%), two in 17 (30.9%), three in 5 (9.1%), four in 6 (10.9%), and five in 2 patients (3.6%). Overall, ICAS was most commonly located in the anterior circulation (n = 61, 55.5%), especially in the left M1 segment (15.5%) and in the right M1 segment (12.7%).

Table 4 Site of ICAS ≥ 50%

Location	≥ 50% (N = 54)	Subocclusion/occlusion (N = 56)	Total
Right – TICA	7	2	9 (8.2%)
Right – M1CA	6	8	14 (12.7%)
Right – M2CA	0	5	5 (4.5%)
Right – ACA	4	1	5 (4.5%)
Right – P1CA	7	2	9 (8.2%)
Right – P2CA	2	1	3 (2.7%)
Right – VA	0	9	9 (8.2%)
BA	2	7	9 (8.2%)
Left – TICA	3	1	4 (3.6%)
Left – M1MCA	9	8	17 (15.5%)
Left – M2MCA	3	2	5 (4.5%)
Left – ACA	1	1	2 (1.8%)
Left – P1CA	5	1	6 (5.5%)
Left – P2CA	4	1	5 (4.5%)
Left – VA	1	7	8 (7.3%)

Abbreviations: ACA, anterior cerebral artery; BA, basilar artery; ICAS, intracranial arterial stenosis; M1CA, M1 segment of the middle cerebral artery; M2CA, M2 segment of the middle cerebral artery; P1CA, P1 segment of the posterior cerebral artery; P2CA, P2 segment of the posterior cerebral artery; TICA, terminal internal carotid artery; VA, vertebral artery.

The TCCS showed a good performance in predicting ICAS compared with CTA (Coehn kappa: 0.58; area under the curve [AUC]: 0.88; 95% CI 0.69–0.92; p < 0.0001) with 74% of sensitivity, 87% of specificity, 65% of predictive positive value, and 90% of predictive negative value ([Figure 1] and [Table 5]).

Figure 1 (A) Intracranial stenosis in the M1 segment of the left middle cerebral artery detected by TCCS (mean flow velocity of 169.1 cm/s). (B) Confirmation by computed tomography angiography (white arrow).

Table 5 Performance of TCCS compared with CTA in MCA ≥ 50% of 100 patients

	MCA	95%CI
AUC	0.88	0.69–0.92
Sensitivity	0.74	0.53–0.87
Specificity	0.87	0.76–0.93
PPV	0.65	0.49–0.78
NPV	0.90	0.83–0.95
LR+	5.58	2.9–0.75
LR-	0.30	0.15–0.60

Abbreviations: AUC, area under the curve; CI, confidence interval; CTA, computed tomographic angiography; LR + , positive likelihood ratio; LR-, negative likelihood ratio; MCA, middle cerebral artery; NPV, negative predictive value; PPV, positive predictive value; TCCS, transcranial color-coded duplex sonography.

DISCUSSION

This study performed at a public tertiary academic stroke center in Brazil found a high frequency (38.5%) of ICAS compared with other Western studies, which indicated 8 to 10% of occurrence.[18] [19] To the best of our knowledge, no previous study evaluating the frequency and severity of ICAS assessed by TCCS has been provided in Brazil, and limited studies have investigated the prevalence of this condition in Brazilian patients by other methods. Despite 15.9% of inadequate transtemporal echo-window, we were able to show high rates of ICAS with consecutive enrollment of acute stroke patients evaluated by the same methodology. We believe that one of the reasons for the high rates found in our study may be the systematic investigation of the intracranial vasculature.

It is important to mention that none of our patients met clinical and/or radiological suspicion criteria for vasculitis, inflammatory arteriopathies, intracranial dissection, or reversible cerebral vasoconstriction syndrome. We also excluded from the sample patients who presented clinical and laboratory criteria for anemia, which allows us to assume that the sample analyzed possibly corresponds to the intracranial atherosclerotic disease.

Stroke is a heterogeneous disease, and intracranial atherosclerosis is considered one of the most common causes of AIS worldwide.[20] [21] Its incidence and prevalence vary between geographical regions and ethnicities, even in Asian countries, where it accounts for about 50% of cases.[22] [23] In Western countries, ICAS has historically been poorly studied and may be underestimated compared to extracranial lesions.[18] [24] [25] In 1995, Sacco et al. found 8% of intracranial atherosclerosis in a stroke population of 438 patients (35% Black, 46% Hispanic, and 19% White). The rate of extracranial atherosclerosis was similar between ethnic groups; however, intracranial lesions were more frequent in Blacks and Hispanics (OR: 7.8; 95% CI: 1.04–57.7).[19] In the present study, there wasn't a significant difference between ethnic groups (p = 0.44). However, 69.1% of our patients with ICA were White.

Another reason for the high rates of intracranial atherosclerosis is the poor control of classic risk factors for cerebrovascular diseases found in our sample. Systemic arterial hypertension was the most frequent risk factor in our patients, with a prevalence rate of 76.9%, followed by prior stroke or TIA (44.1%), diabetes (40.6%), and dyslipidemia (39.2%). A study conducted on stroke patients detected that those with MCA stenosis had a higher prevalence of hypertension, hypercholesterolemia, and diabetes.[26] Several other studies have also indicated a correlation between high blood pressure and ICAS.[27] [28] [29]

In our study, systolic blood pressure on admission was significantly higher in patients with ICAS (p < 0.001) and it was the only independently associated risk factor found in the multivariate analysis. One of the pathophysiological explanations for this might be a preexistent history of systemic arterial hypertension.

This data is consistent with other studies, including stroke-free populations with intracranial atherosclerosis.[30] [31] [32] A Chinese study performed between 2009 and 2013 also showed a strong correlation between high blood pressure and symptomatic atherosclerosis of the internal carotid artery (OR: 5.98; 95% CI: 1.79–19.98) and other asymptomatic intracranial atherosclerosis (OR: 2.56; 95% CI: 1.22–5.37).[33]

Of the 56 (39.2%) previously dyslipidemic patients, only 24 (42.8%) were taking statins. The correct use of statins was found in 15 (17.0%) patients without ICAS and in only 9 (16.4%) of those with diagnosis, demonstrating a failure to control one of the most critical risk factors for atherosclerosis and stroke.

Concerning stroke severity, patients with ICAS had higher NIHSS scores (p = 0.004) on admission, which may demonstrate a trend to more severe strokes in these circumstances, similar to previous studies.[34] Nevertheless, this data was not statistically significant, nor was associated with functional outcomes and mortality at 3 months. A study conducted by Lau et al. with 39% of ICAS prevalence checked by CTA, the patients had more severe strokes (median NIHSS: 9 vs. 3; p < 0.001), worse outcomes at 6 months (mRS: 0–2; 57 vs. 73%; p < 0.001), and higher mortality (18 vs. 8%; p = 0.001).[35]

Many previous studies reported an association between low levels of HDL and the development of intracranial atherosclerosis.[36] In an analysis of the CICAS study, low HDL levels are strongly associated with the development of ICAS with an inverse relationship between both (p = 0.001).[37] In our study, the level of HDL was significantly lower in patients without ICAS than in those with (p = 0.02).

Our study has some limitations, mainly because the TCCS is an operator-dependent technique and can sometimes result in incomplete assessments due to unsatisfactory transtemporal bone windows. However, it offers a noninvasive option that can be easily and quickly repeatable at the bedside, allowing accurate evaluation of cerebral blood flow and providing information about anatomical structures.[6] [15] [38] Furthermore, we performed the study in a single center, and the results were limited to patients with AIS or TIA. Despite previously mentioned limitations, it is essential to note that all selected patients were consecutively evaluated by TCCS, and the characteristics of patients with and without transcranial windows were similar, reducing the possibility of a relevant selection bias. Another possible limitation was that we could not perform CTA on all patients due to contraindications. Nevertheless, our results support the application of TCCS as a diagnostic strategy in Brazilian stroke centers, particularly those lacking more modern imaging techniques.

In conclusion, our study shows that ICAS is a common condition in our population, identified in about one third of patients admitted with AIS or TIA. Most of these ICAS were symptomatic and considered to be culprits for the stroke episodes. Due to the high prevalence of significant ICAS in the Brazilian population, it is believed that inclusion of TCCS is essential as a bedside examination to evaluate stroke etiology, particularly in patients with high blood pressure on admission. These preliminary findings support further collaborative initiatives among stroke physicians to increase ICAS detection in Brazilian patients with AIS or TIA.

Conflict of Interest

The authors have no conflict of interest to declare.

Acknowledgments

OMPN would like to thank the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Científico e Tecnológico - CNPq) for the research grant used for this study.

Authors' Contributions

LJAR: conceptualization, data curation, formal analysis, investigation, methodology, project administration, supervision, visualization, writing – original draft, and writing – review and editing; MCZZ, RSA, MCL: investigation, methodology, writing – review & editing; MRC: conceptualization, formal analysis, methodology, visualization, writing – original draft, and writing – review and editing; CMAB: investigation, methodology, and writing – review and editing; PTCP: conceptualization, methodology, visualization, writing – original draft, and writing – review and editing; SCM: formal analysis, writing – original draft; DGA: methodology, visualization, and writing – review and editing; OMPN: conceptualization, data curation, formal analysis, investigation, methodology, project administration, supervision, visualization, writing – original draft, and writing – review and editing.

• References

• 1 Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke 2008; 39 (08) 2396-2399
• 2 Del Brutto OH, Mera RM, Lama J, Zambrano M, Del Brutto VJ. Intracranial arterial stenosis in Ecuadorian Natives/Mestizos. A population-based study in older adults (The Atahualpa Project). Arch Gerontol Geriatr 2015; 61 (03) 480-483
• 3 Feldmann E, Wilterdink JL, Kosinski A. et al; Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) Trial Investigators. The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology 2007; 68 (24) 2099-2106
• 4 Felberg RA, Christou I, Demchuk AM, Malkoff M, Alexandrov AV. Screening for intracranial stenosis with transcranial Doppler: the accuracy of mean flow velocity thresholds. J Neuroimaging 2002; 12 (01) 9-14
• 5 Lange MC, Bruch TP, Pedrozo JC. et al. The use of neurovascular ultrasound versus digital subtraction angiography in acute ischemic stroke. Arq Neuropsiquiatr 2015; 73 (03) 218-222
• 6 Aries MJH, Elting JW, De Keyser J, Kremer BPH, Vroomen PCAJ. Cerebral autoregulation in stroke: a review of transcranial Doppler studies. Stroke 2010; 41 (11) 2697-2704
• 7 Bathala L, Mehndiratta MM, Sharma VK. Cerebrovascular ultrasonography: Technique and common pitfalls. Ann Indian Acad Neurol 2013; 16 (01) 121-127
• 8 Brisson RT, Santos RDSA, Stefano LHSS. et al. Association between Tomographic Characteristics of the Temporal Bone and Transtemporal Window Quality on Transcranial Color Doppler Ultrasound in Patients with Stroke or Transient Ischemic Attack. Ultrasound Med Biol 2021; 47 (03) 511-516
• 9 Association between Tomographic Characteristics of the Temporal Bone and Transtemporal Window Quality on Transcranial Color Doppler Ultrasound in Patients with Stroke or Transient Ischemic Attack - Ultrasound in Medicine and Biology [Internet]. [cited 2023 Nov 29]. Available from: https://www.umbjournal.org/article/S0301-5629(20)30486-5/fulltext
• 10 Arenillas JF, Molina CA, Montaner J, Abilleira S, González-Sánchez MA, Alvarez-Sabín J. Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: a long-term follow-up transcranial Doppler ultrasound study. Stroke 2001; 32 (12) 2898-2904
• 11 Brott T, Adams Jr HP, Olinger CP. et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20 (07) 864-870
• 12 de Haan R, Limburg M, Bossuyt P, van der Meulen J, Aaronson N. The clinical meaning of Rankin ‘handicap’ grades after stroke. Stroke 1995; 26 (11) 2027-2030
• 13 Cincura C, Pontes-Neto OM, Neville IS. et al. Validation of the National Institutes of Health Stroke Scale, modified Rankin Scale and Barthel Index in Brazil: the role of cultural adaptation and structured interviewing. Cerebrovasc Dis 2009; 27 (02) 119-122
• 14 Adams Jr HP, Bendixen BH, Kappelle LJ. et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24 (01) 35-41
• 15 Marinoni M, Ginanneschi A, Forleo P, Amaducci L. Technical limits in transcranial Doppler recording: inadequate acoustic windows. Ultrasound Med Biol 1997; 23 (08) 1275-1277
• 16 Baumgartner RW, Mattle HP, Schroth G. Assessment of >/=50% and <50% intracranial stenoses by transcranial color-coded duplex sonography. Stroke 1999; 30 (01) 87-92
• 17 Zhao L, Barlinn K, Sharma VK. et al. Velocity criteria for intracranial stenosis revisited: an international multicenter study of transcranial Doppler and digital subtraction angiography. Stroke 2011; 42 (12) 3429-3434
• 18 Arenillas JF. Intracranial atherosclerosis: current concepts. Stroke 2011; 42 (1, Suppl) S20-S23
• 19 Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995; 26 (01) 14-20
• 20 You Y, Hao Q, Leung T. et al. Detection of the siphon internal carotid artery stenosis: transcranial Doppler versus digital subtraction angiography. J Neuroimaging 2010; 20 (03) 234-239
• 21 White H, Boden-Albala B, Wang C. et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation 2005; 111 (10) 1327-1331
• 22 Wong KS, Huang YN, Gao S, Lam WW, Chan YL, Kay R. Intracranial stenosis in Chinese patients with acute stroke. Neurology 1998; 50 (03) 812-813
• 23 Wong LKS. Global burden of intracranial atherosclerosis. Int J Stroke 2006; 1 (03) 158-159
• 24 Klötzsch C, Popescu O, Sliwka U, Mull M, Noth J. Detection of stenoses in the anterior circulation using frequency-based transcranial color-coded sonography. Ultrasound Med Biol 2000; 26 (04) 579-584
• 25 Viaro F, Farina FM, Onofri A, Meneghetti G, Baracchini C. Symptomatic intracranial stenosis: A university hospital-based ultrasound study. Perspect Med 2012; 1–12 (1–12): 211-213
• 26 Jeng JS, Hsieh FI, Yeh HL. et al; Taiwan Stroke Registry Investigators. Impact of MCA stenosis on the early outcome in acute ischemic stroke patients. PLoS One 2017; 12 (04) e0175434
• 27 Wang D, Zhou Y, Guo Y. et al. Arterial pre-hypertension and hypertension in intracranial versus extracranial cerebrovascular stenosis. Eur J Neurol 2015; 22 (03) 533-539
• 28 Yu DD, Pu YH, Pan YS. et al; Chinese Intracranial Atherosclerosis (CICAS) Study Group. High Blood Pressure Increases the Risk of Poor Outcome at Discharge and 12-month Follow-up in Patients with Symptomatic Intracranial Large Artery Stenosis and Occlusions: Subgroup analysis of the CICAS Study. CNS Neurosci Ther 2015; 21 (06) 530-535
• 29 Ye F, Yu NW, Wu WB, Guo FQ. Impact of awake blood pressure variability on cerebrovascular atherosclerosis in Chinese patients with acute ischemic stroke. Blood Press Monit 2016; 21 (05) 271-276
• 30 Oh HG, Chung PW, Rhee EJ. Increased risk for intracranial arterial stenosis in subjects with coronary artery calcification. Stroke 2015; 46 (01) 151-156
• 31 Huang HW, Guo MH, Lin RJ. et al. Prevalence and risk factors of middle cerebral artery stenosis in asymptomatic residents in Rongqi County, Guangdong. Cerebrovasc Dis 2007; 24 (01) 111-115
• 32 Mo Y, Zhou J, Li M. et al. Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients. Cardiovasc Diabetol 2013; 12 (01) 15
• 33 Chen H, Hong H, Xing S. et al. Intracranial versus extracranial artery dissection cases presenting with ischemic stroke. J Stroke Cerebrovasc Dis 2015; 24 (04) 852-859
• 34 Ma Y, Liu L, Pu Y. et al. Predictors of neurological deterioration during hospitalization: results from the Chinese Intracranial Atherosclerosis (CICAS) Study. Neurol Res 2015; 37 (05) 385-390
• 35 Lau AY, Wong KSL, Lev M, Furie K, Smith W, Kim AS. Burden of intracranial steno-occlusive lesions on initial computed tomography angiography predicts poor outcome in patients with acute stroke. Stroke 2013; 44 (05) 1310-1316
• 36 Kim BJ, Hong KS, Cho YJ. et al; TOSS-2 investigators. Predictors of symptomatic and asymptomatic intracranial atherosclerosis: what is different and why?. J Atheroscler Thromb 2014; 21 (06) 605-617
• 37 Qian Y, Pu Y, Liu L. et al. Low HDL-C level is associated with the development of intracranial artery stenosis: analysis from the Chinese IntraCranial AtheroSclerosis (CICAS) study. PLoS One 2013; 8 (05) e64395 . Doi: 10.1371%2Fjournal.pone.0064395
• 38 Bass A, Krupski WC, Schneider PA, Otis SM, Dilley RB, Bernstein EF. Intraoperative transcranial Doppler: limitations of the method. J Vasc Surg 1989; 10 (05) 549-553

Publikationsverlauf

Eingereicht: 23. Januar 2024

Angenommen: 18. Mai 2024

Artikel online veröffentlicht:
08. August 2024